Polyrizon Competitors and Similar CompaniesClear all

FibroGen's competitors and similar companies include Corcept Therapeutics and CanSino Biologics.

	FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.	Corcept Therapeutics Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators.	CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.
Founding Date	Founding Date 1993	Founding Date 1998	Founding Date 2009
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development	Tags Healthcare biotech clinical research drug development	Tags Healthcare biotech clinical research drug development
Locations	Locations San Francisco, US HQ	Locations Redwood City, US HQ	Locations Tianjin, CN HQ
Employees	Employees 53115% increase	Employees 50042% increase	Employees 1,10526% decrease
Valuation ($)	Valuation ($) 30.7 m	Valuation ($) 5 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $6.4m (FY, 2025)	Revenue (est.) $761.4m (FY, 2025)	Revenue (est.) ¥1.1b (FY, 2025)
Cost of goods	Cost of goods $556k (FY, 2025)	Cost of goods $13m (FY, 2025)	Cost of goods ¥81.4m (FY, 2025)
Gross profit	Gross profit $5.9m (FY, 2025)	Gross profit $748.4m (FY, 2025)	Gross profit ¥1.1b (FY, 2025)
Net income	Net income $183.5m (FY, 2025)	Net income $99.7m (FY, 2025)	Net income ¥27.9m (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 80.1m	Total funding raised $ 76m